Interestingly, the presence of sPD-1 would confer a pro-immunologic role to this molecule, since its binding to the membrane-associated PD-L1 on tumor or APCs would act as a PD-L1 blocking agent, thus preventing the inhibition of T cells through the PD-1/PD-L1 axis. Here, HOXD13 is linked to neoplasm.